Split History
ETFs Holding CBIO »    CBIO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Catalyst Biosciences is a clinical-stage biotechnology company focused on developing novel medicines to address hematology indications, including the treatment of hemophilia. As of Dec 31 2016, Co. is focused on the clinical development of subcutaneous prophylaxis using enhanced potency: Factor VIIa, Marzeptacog alfa, for treatment of individuals with severe hemophilia A and B with inhibitors; and Factor IX drug for the prophylactic treatment of individuals with hemophilia B. According to our CBIO split history records, Catalyst Biosciences has had 2 splits.
CBIO split history picture
Catalyst Biosciences (CBIO) has 2 splits in our CBIO split history database. The first split for CBIO took place on August 21, 2015. This was a 1 for 7 reverse split, meaning for each 7 shares of CBIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split. CBIO's second split took place on February 13, 2017. This was a 1 for 15 reverse split, meaning for each 15 shares of CBIO owned pre-split, the shareholder now owned 1 share. For example, a 142.857142857143 share position pre-split, became a 9.52380952380952 share position following the split.

When a company such as Catalyst Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the CBIO split history from start to finish, an original position size of 1000 shares would have turned into 9.52380952380952 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Catalyst Biosciences shares, starting with a $10,000 purchase of CBIO, presented on a split-history-adjusted basis factoring in the complete CBIO split history. CBIO split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 05/29/2007
End date: 05/26/2017
Start price/share: $1,034.25
End price/share: $4.27
Starting shares: 9.67
Ending shares: 15.40
Dividends reinvested/share: $59.74
Total return: -99.34%
Average Annual Total Return: -39.49%
Starting investment: $10,000.00
Ending investment: $65.81
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/29/2007
End date: 05/26/2017
Start price/share: $1,034.25
End price/share: $4.27
Dividends collected/share: $59.74
Total return: -93.81%
Average Annual Total Return: -24.29%
Starting investment: $10,000.00
Ending investment: $618.77
Years: 10.00
Date Ratio
08/21/20151 for 7
02/13/20171 for 15
CBIO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

CBLI Split History
CBM Split History
CBMX Split History
CBRX Split History
CCM Split History
CDXC Split History
CELG Split History
CERE Split History
CGC Split History
CGNT Split History

Yield10 Bioscience, Inc. (YTEN)
Xerox Corporation (XRX)
Waste Connections, Inc. (WCN)
Spark Energy, Inc. (SPKE)
MagneGas Corporation (MNGA)
Frontier Communications Corporation (FTR)
NeuroMetrix, Inc. (NURO)
Pain Therapeutics, Inc. (PTIE)
Rex Energy Corporation (REXX)
Rexahn Pharmaceuticals, Inc. (RNN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

CBIO Insider Buying

CBIO Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.